Selective loading of 5-fluorouracil in the interlayer space of methoxy-modified kaolinite for controlled release
Source abstract
Abstract
Abstract Methoxy-modified kaolinite was used as a novel carrier for anticancer drug 5-fluorouracil (5FU). The selective loading of 5FU into the interlayer space of methoxy-modified kaolinite was achieved because the weakly bonded 5FU on the external surface was removed off by facile water rinse. The intercalated 5FU has strong affinity (electrostatic force and hydrogen bonding) with the interlayer surface of kaolinite, and its release was controlled because of the diffusion restriction of the kaolinite lamellar layers and the strong affinity between 5FU and kaolinite. The controlled release of 5FU from methoxy-modified kaolinite in simulated colonic fluid (pH 5.5) makes it be of potential use to administer an oral formulation of 5FU for colon specific delivery.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Clay minerals and soil interactions · Oral health in cancer treatment · Therapeutic Uses of Natural Elements
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Adsorption and interaction of 5-fluorouracil with montmorillonite and saponite by FT-IR spectroscopy10.1016/j.molstruc.2006.11.061 ↗
2. A study on sustained release formulations for oral delivery of 5-fluorouracil based on alginate–chitosan/montmorillonite nanocomposite systems10.1016/j.clay.2014.09.004 ↗
3. Analytical profile of 5-fluorouracil10.1016/S0099-5428(08)60682-6 ↗
4. Adsorption of salicylic acid on bentonite and kaolin and release experiments10.1016/j.clay.2006.07.008 ↗
5. Clay and non-clay minerals in the pharmaceutical industry Part I. Excipients and medical applications10.1016/j.clay.2009.07.017 ↗
6. Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients10.1016/j.clay.2009.10.016 ↗
7. Bulk and surface properties of commercial kaolins10.1016/j.clay.2010.02.002 ↗
8. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
9. Loading and release of 5-fluorouracil from HY zeolites with varying SiO2/Al2O3 ratios10.1016/j.micromeso.2012.09.011 ↗
10. Clinical pharmacology of 5-fluorouracil10.2165/00003088-198916040-00002 ↗
11. Intercalation of halloysite: a Raman spectroscopic study10.1346/CCMN.1997.0450407 ↗
12. Porous clay heterostructures: a new inorganic host for 5-fluorouracil encapsulation10.1016/j.ijpharm.2015.05.053 ↗
13. Kinetic insights into the role of the solvent in the polymorphism of 5-fluorouracil from molecular dynamics simulations10.1021/jp055982e ↗
14. Thermal characterization of surfactant-modified montmorillonites10.1346/CCMN.2005.0530308 ↗
15. The infrared spectra of secondary amines and their salts10.1139/v56-231 ↗
16. Preparation of 5-fluorouracil/β-cyclodextrin complex intercalated in layered double hydroxide and the controlled drug release properties10.1021/ie100990z ↗
17. Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU)10.1016/j.ejpb.2012.01.004 ↗
18. Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting10.1016/j.ijpharm.2010.11.025 ↗
19. Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends10.1016/j.carbpol.2011.03.045 ↗
20. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier10.1016/S0142-9612(01)00325-8 ↗
21. Cation exchange capacity of kaolinite10.1346/CCMN.1999.0470207 ↗
22. Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin10.1016/j.ejpb.2007.06.003 ↗
23. Sustained release of 5-fluorouracil from polymeric nanoparticles10.1211/0022357001777658 ↗
24. Spectroscopic and physical-chemical characterization of ambazone-glutamate salt10.1155/2011/414103 ↗
25. pH sensitive halloysite-sodium hyaluronate/poly(hydroxyethyl methacrylate) nanocomposites for colon cancer drug delivery10.1016/j.clay.2014.06.002 ↗
26. Biodegradable and thermo-sensitive chitosan-g-poly(N-vinylcaprolactam) nanoparticles as a 5-fluorouracil carrier10.1016/j.carbpol.2010.08.052 ↗
27. 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) polymers10.1016/j.ijpharm.2007.02.001 ↗
28. Freezing behavior in porous glasses and MCM-4110.1016/S0927-7757(01)00637-9 ↗
29. Controlled release of the herbicide norflurazon into water from ethylcellulose formulations10.1021/jf048007d ↗
30. Controlled release of 5-fluorouracil from microporous zeolites10.1016/j.nano.2013.06.016 ↗
31. High-capacity loading of 5-fluorouracil on the methoxy-modified kaolinite10.1016/j.clay.2014.02.022 ↗
32. Methoxy-modified kaolinite as a novel carrier for high-capacity loading and controlled-release of the herbicide amitrole10.1038/srep08870 ↗
33. Surface modifications of halloysite
34. The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents10.2174/1389201003378979 ↗
35. Preparation and characterization of an 8.4-angstrom hydrate of kaolinite10.1346/CCMN.1994.0420414 ↗
36. Chemically modified kaolinite. Grafting of methoxy groups on the interlamellar aluminol surface of kaolinite10.1039/jm9960601679 ↗
37. Synthesis and properties of Mg2Al layered double hydroxides containing 5-fluorouracil10.1016/j.jssc.2004.11.005 ↗
38. Chitosan/alginate nanoparticles stabilized by poloxamer for the controlled release of 5-fluorouracil10.1002/app.32083 ↗
39. Effect of reaction temperature on grafting of γ-aminopropyl triethoxysilane (APTES) onto kaolinite10.1016/j.clay.2012.04.006 ↗
40. Supramolecular assemblies constructed from [small beta]-cyclodextrin-modified montmorillonite nanosheets as carriers for 5-fluorouracil10.1039/C5TB01513H ↗
41. In vitro release of 5-fluorouracil with cyclic core dendritic polymer10.1016/S0168-3659(98)00120-5 ↗